go-v.orgdoi

Clinical Characteristics and Oncological Outcomes of Surgically Treated Early-Onset Gastric Adenocarcinoma - a Retrospective Cohort Study

Ingmar Florin Rompen, Henrik Nienhüser, Nerma Crnovrsanin, Julian Musa, Georg Martin Haag, Thomas Longerich, Timon Fiedler, Beat Peter Müller-Stich, Leila Sisic, Adrian Theophil Billeter · Journal of Cancer · 2023

  • DOI 10.7150/jca.82876
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2023

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2023

Abstract

Introduction:The incidence of early-onset gastric adenocarcinoma (patients <50 years, EOGA) is rising.Tumors in younger patients are associated with prognostically unfavorable features.The impact of EOGA on patient survival, however, remains unclear.The aim of this study is to evaluate early-onset age as a prognostic factor compared to late-onset gastric adenocarcinoma (LOGA, >50years) in a surgical cohort and assess treatment options.Methods: We analyzed 738 patients (129 early-onset/609 late-onset) operated in curative intent from 2002 to 2021.Data was extracted from a prospectively managed database of an academic tertiary referral hospital.Differences in perioperative as well as oncological outcomes were calculated by chi-square test.Cox regression analysis was performed to assess disease-free survival (DFS) and overall survival (OS).Results: EOGA patients were more often treated with neoadjuvant therapy (62.8% vs.

43.7%,p<0.001) and extended surgical resections e.g. through additional resections (36.4% vs. 26.8%,p=0.027).EOGA was more often metastasized into regional lymph nodes (pN+ 67.4% vs. 55.3%, p=0.012) and to distant sites (pM+: 23.3% vs. 12.0%, p=0.001) and was more often poorly differentiated (G3/G4: 91.1% vs. 67.2%,p<0.001).There were no significant differences in overall complication rates (31.0% vs.

36.6%,p=0.227).Survival analysis showed shorter DFS (median DFS 25.6 months vs. not reached, p=0.006) but similar OS (median OS: 50.5 months vs. not reached, p=0.920) in EOGA compared to LOGA.Conclusions: This analysis confirmed that EOGA is associated with more aggressive tumor characteristics.Early-Onset was not a prognostic factor in the multivariate analysis.EOGA patients may be more capable to undergo intensive multimodal therapy including perioperative chemotherapy and extended surgery.

Open the resolved locator · 10.7150/jca.82876

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-20 00:12 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v14p1470.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.